Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Natraj Proteins
Join Channel
Consolidated Standalone

Natraj Proteins

₹39.1 -0.6 | 1.6%

Market Cap ₹15 Cr.

Stock P/E -1.2

P/B 0.5

Current Price ₹39.1

Book Value ₹ 82.8

Face Value 10

52W High ₹51.6

Dividend Yield 0%

52W Low ₹ 32.4

Edit Ratio

Natraj Proteins Research see more...

Overview Inc. Year: 1990Industry: Edible Oil

Natraj Proteins Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Natraj Proteins Quarterly Results

#(Fig in Cr.) Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 50 41 36 78 39 39 23 33 23 27
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 50 41 36 78 39 39 23 33 23 27
Total Expenditure 49 46 41 79 37 40 23 33 21 27
Operating Profit 1 -5 -5 -1 2 -1 -0 1 2 -1
Interest 1 1 1 1 1 1 1 1 1 1
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 -6 -6 -2 1 -2 -1 0 1 -1
Provision for Tax 0 0 0 0 0 -0 0 0 0 0
Profit After Tax 0 -6 -6 -2 1 -2 -1 0 1 -1
Adjustments 0 0 -0 -0 0 0 0 0 0 0
Profit After Adjustments 0 -6 -6 -2 1 -2 -1 0 1 -1
Adjusted Earnings Per Share 0.7 -16.4 -15 -4.7 2.7 -4.6 -2.7 0.1 3.4 -3.2

Natraj Proteins Profit & Loss

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
Net Sales 364 302 201 258 194 191 154 146 145 144 194 106
Other Income 0 1 1 1 0 0 0 0 0 0 0 0
Total Income 364 303 201 259 195 191 154 146 145 144 194 106
Total Expenditure 348 296 202 254 188 185 150 143 131 141 203 104
Operating Profit 16 7 -1 5 7 6 5 3 14 3 -9 2
Interest 3 5 3 4 4 4 4 2 1 2 3 4
Depreciation 1 1 1 1 1 1 1 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 12 2 -5 0 2 1 0 1 13 1 -12 -1
Provision for Tax 4 0 -0 0 0 0 -0 1 4 0 0 0
Profit After Tax 8 2 -5 0 2 1 0 0 9 1 -13 -1
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 8 2 -5 0 2 1 0 0 9 1 -13 -1
Adjusted Earnings Per Share 21.6 4.1 -14.2 0.6 4.3 3.1 0.9 1.1 25 1.9 -33.4 -2.4

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 35% 10% 0% -6%
Operating Profit CAGR -400% NAN% NAN% NAN%
PAT CAGR -1400% 0% NAN% NAN%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -19% -15% 22% 3%
ROE Average -31% -2% -1% 2%
ROCE Average -12% 4% 5% 6%

Natraj Proteins Balance Sheet

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Shareholder's Funds 38 38 33 33 34 35 36 36 45 46 34
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 2 1 0 0 0 0 0 0 3 3 1
Other Non-Current Liabilities 2 1 1 1 1 1 1 1 1 1 1
Total Current Liabilities 57 56 37 32 71 36 34 31 26 40 42
Total Liabilities 99 95 71 65 106 73 71 68 76 89 78
Fixed Assets 9 6 5 4 4 4 3 3 4 4 5
Other Non-Current Assets 6 8 5 7 5 3 2 5 8 10 9
Total Current Assets 85 81 61 54 98 66 65 61 64 75 63
Total Assets 99 95 71 65 106 73 71 68 76 89 78

Natraj Proteins Cash Flow

#(Fig in Cr.) Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Opening Cash & Cash Equivalents 16 10 20 6 3 0 4 2 0 5 2
Cash Flow from Operating Activities -13 25 9 3 -37 30 2 9 6 3 -6
Cash Flow from Investing Activities -0 -2 4 -2 3 2 0 -0 -3 -3 0
Cash Flow from Financing Activities 7 -13 -27 -4 31 -28 -4 -10 2 -2 3
Net Cash Inflow / Outflow -7 10 -14 -3 -3 4 -2 -2 5 -2 -2
Closing Cash & Cash Equivalent 10 20 6 3 0 4 2 0 5 2 1

Natraj Proteins Ratios

# Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Earnings Per Share (Rs) 21.64 4.05 -14.18 0.61 4.29 3.06 0.9 1.05 24.99 1.9 -33.41
CEPS(Rs) 23.78 5.9 -12.21 2.3 5.88 4.8 2.59 2.12 26.04 3.04 -32.22
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 101.05 101.14 86.88 87.24 91.56 94.43 95.11 96.26 121.32 123.39 89.96
Core EBITDA Margin(%) 4.18 1.97 -0.88 1.53 3.29 3.15 2.93 2.11 9.79 2.08 -4.83
EBIT Margin(%) 4.1 2.06 -0.96 1.5 3.1 2.92 2.55 1.91 9.69 1.93 -4.91
Pre Tax Margin(%) 3.35 0.56 -2.65 0.12 0.91 0.71 0.21 0.67 8.95 0.71 -6.43
PAT Margin (%) 2.23 0.5 -2.64 0.09 0.82 0.6 0.22 0.27 6.47 0.5 -6.46
Cash Profit Margin (%) 2.45 0.73 -2.28 0.33 1.13 0.94 0.63 0.54 6.74 0.79 -6.23
ROA(%) 9.13 1.56 -6.39 0.33 1.87 1.28 0.47 0.56 12.98 0.86 -14.98
ROE(%) 23.99 4.01 -15.09 0.7 4.79 3.29 0.95 1.1 22.97 1.55 -31.32
ROCE(%) 18.65 7.33 -2.91 7.49 8.65 7.19 5.93 4.47 21.43 3.64 -12.38
Receivable days 6.3 12.61 17.4 11.77 23.71 32.7 44.63 40.63 40.26 37.52 27.59
Inventory Days 53.01 66.66 80.45 56.82 109.36 117.24 98.66 108.95 107.21 122 94.75
Payable days 3.1 10.38 22.81 17.8 27.32 20.16 7.7 12.92 12.55 10.33 7.79
PER(x) 1.39 10.38 0 52.84 6.85 8.79 24.44 26.38 4.21 20.31 0
Price/Book(x) 0.3 0.42 0.3 0.37 0.32 0.28 0.23 0.29 0.87 0.31 0.43
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0.14 0.13 0.11 0.11 0.33 0.19 0.24 0.22 0.43 0.32 0.28
EV/Core EBITDA(x) 3.34 5.61 -19.28 6.07 9.73 5.93 8.06 10.13 4.29 14.29 -5.95
Net Sales Growth(%) 13.88 -17.03 -33.52 28.86 -24.78 -1.9 -19.18 -5.13 -1.03 -0.77 34.91
EBIT Growth(%) -24.5 -58.32 -131.13 300.56 56.22 -8.18 -29.24 -29.14 403.09 -80.2 -442.59
PAT Growth(%) -25.31 -81.28 -450.11 104.28 606.37 -28.59 -70.44 16.12 2279.21 -92.39 -1856.07
EPS Growth(%) -25.31 -81.28 -450.11 104.28 606.41 -28.59 -70.44 16.12 2279.16 -92.39 -1856.05
Debt/Equity(x) 1.34 1.13 0.6 0.58 1.58 0.87 0.87 0.61 0.6 0.73 1.19
Current Ratio(x) 1.48 1.46 1.65 1.71 1.38 1.84 1.91 1.94 2.42 1.89 1.51
Quick Ratio(x) 0.32 0.67 0.44 0.57 0.23 0.7 0.68 0.51 0.91 0.48 0.45
Interest Cover(x) 5.5 1.37 -0.57 1.09 1.42 1.32 1.09 1.54 13.08 1.58 -3.23
Total Debt/Mcap(x) 4.52 2.72 1.98 1.57 4.93 3.06 3.73 2.14 0.69 2.33 2.75

Natraj Proteins Shareholding Pattern

# Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 44.88 44.38 43.8 43.68 43.25 42.63 42.23 42.16 42.16 42.14
FII 0 0 0 0 0 0 0 0 0 0
DII 1.93 1.93 1.93 1.93 1.93 1.93 1.93 1.93 1.93 1.93
Public 53.19 53.69 54.27 54.39 54.82 55.44 55.84 55.91 55.91 55.93
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Stock is trading at 0.5 times its book value
  • Debtor days have improved from 10.33 to 7.79days.
  • Company has reduced debt.

Cons

  • Promoter holding is low: 42.14%.
  • Company has a low return on equity of -2% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Natraj Proteins News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot Listing Price Listing Gain(%) Current Price Return (%) Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!